{"id":5945,"date":"2025-08-08T23:02:37","date_gmt":"2025-08-08T23:02:37","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/08\/08\/fda-george-tidmarsh-vinay-prasad-staff-concerns\/"},"modified":"2025-08-08T23:02:37","modified_gmt":"2025-08-08T23:02:37","slug":"fda-george-tidmarsh-vinay-prasad-staff-concerns","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/08\/08\/fda-george-tidmarsh-vinay-prasad-staff-concerns\/","title":{"rendered":"In internal FDA town hall, employees raise concerns about staffing, impromptu expert meetings\u00a0"},"content":{"rendered":"<p>    In internal FDA town hall, employees raise concerns about staffing, impromptu expert meetings\u00a0<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>WASHINGTON \u2014 Top drug regulator George Tidmarsh assured Food and Drug Administration staff this week that he and other leaders are trying to bring operations back to normal.\u00a0<\/p>\n<p>\u201cI know that I\u2019m coming in here at a challenging time,\u201d Tidmarsh said at a town hall meeting on Friday with the Center for Drug Evaluation and Research staff. \u201cThat is not lost on me.\u201d\u00a0<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/08\/08\/fda-george-tidmarsh-vinay-prasad-staff-concerns\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Lizzy Lawrence<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/08\/08\/fda-george-tidmarsh-vinay-prasad-staff-concerns\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In internal FDA town hall, employees raise concerns about staffing, impromptu expert meetings\u00a0 WASHINGTON \u2014 Top drug regulator George Tidmarsh assured Food and Drug Administration staff this week that he and other leaders are trying to bring operations back to normal.\u00a0 \u201cI know that I\u2019m coming in here at a challenging time,\u201d Tidmarsh said at [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2208,2181,2146,2147,2176,2151,2144,2152],"tags":[2150],"class_list":["post-5945","post","type-post","status-publish","format-standard","hentry","category-biotech","category-drug-development","category-exclusive","category-fda","category-hhs","category-pharma","category-policy","category-politics","category-stat","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/5945"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=5945"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/5945\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=5945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=5945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=5945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}